Evidence map›Paper›PMID 31152320›Full record

ReviewDrug safety2019

Unintended Effects of Communicating About Drug Safety Issues: A Critical Review of the Literature.

Jessica T DeFrank, Lauren McCormack, Suzanne L West, Craig Lefebvre, Olivia Burrus

Abstract readReview
PubMed Publisher
In one paragraph

Review in Drug safety, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Jessica T DeFrankCenter for Communication Science, RTI International, 3040 E. Cornwallis Road, Research Triangle Park, PO Box 12194, NC, USA. jdefrank@rti.org.ORCID http://orcid.org/0000-0002-9224-3709
Lauren McCormackCenter for Communication Science, RTI International, 3040 E. Cornwallis Road, Research Triangle Park, PO Box 12194, NC, USA.
Suzanne L WestCenter for Communication Science, RTI International, 3040 E. Cornwallis Road, Research Triangle Park, PO Box 12194, NC, USA.
Craig LefebvreCenter for Communication Science, RTI International, 3040 E. Cornwallis Road, Research Triangle Park, PO Box 12194, NC, USA.
Olivia BurrusCenter for Communication Science, RTI International, 3040 E. Cornwallis Road, Research Triangle Park, PO Box 12194, NC, USA.

Funding

U.S. Food and Drug Administration U18 FD004608-01
6 · The paper itself

Abstract

Communications about the safety and effectiveness of human drugs can influence patients' and prescribers' perceptions and behaviors, which in turn can affect the public's health more broadly. We conducted a critical review of the literature on the unintended effects from communicating information to the public about safety issues with prescription and over-the-counter drugs. We searched PubMed for peer-reviewed studies published from 1990 to 2017 where study authors reported probable unintended effects of communicating drug safety. The types of communications included in these studies were news reports, direct-to-consumer advertisements, and those released by government agencies. Among the 26 studies identified, the most commonly reported unintended effects were decreased drug use or discontinuation. Other unintended effects included spillover to populations not targeted by the communications (e.g., discontinuation of antidepressants among adults following communications concerning use among youth), shifts in clinical diagnoses (e.g., fewer diagnoses of depression), increased use of alternative therapies, and other undesirable behaviors (e.g., possible increased suicide attempts because antidepressants were discontinued). Limitations to the literature include the inability to establish causation or to isolate the effects of multiple communication sources and messages. Further, because the intended effect of many communications was not known, our study was limited by challenges in defining some effects as unintended. Most studies used health insurer claims data to identify unintended effects of communications, which provide an incomplete picture; few used self-reported or other methodologies that could help illuminate the reasons underlying the effects observed in the claims data. Best practices for communicating about the potential benefits and harms of drugs in a manner that minimizes negative unintended effects are needed to protect and improve public health.

Indexed as

Health BehaviorPublic HealthDrug-Related Side Effects and Adverse ReactionsHealth CommunicationHumansUnited States

Identifiers

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.